Apixaban, an oral direct factor Xa inhibitor, inhibits human clot-bound factor Xa activity in vitro

被引：71
|
作者：
Jiang, Xiaosui [1 ]
Crain, Earl J. [1 ]
Luettgen, Joseph M. [1 ]
Schumacher, William A. [1 ]
Wong, Pancras C. [1 ]
机构：
[1] Bristol Myers Squibb Co, Thrombosis Res, Pennington, NJ 08534 USA
来源：
THROMBOSIS AND HAEMOSTASIS | 2009年 / 101卷 / 04期
关键词：
PROCOAGULANT ACTIVITY; HEPARIN-ANTITHROMBIN; BLOOD-COAGULATION; THROMBOSIS; EFFICACY; INACTIVATION; SAFETY;
D O I：
10.1160/TH08-07-0486
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：780 / 782
页数：3
相关论文
共 50 条
  • [21] Rivaroxaban: An oral direct inhibitor of factor Xa
    Gulseth, Michael P.
    Michaud, Jessica
    Nutescu, Edith A.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2008, 65 (16) : 1520 - 1529
  • [22] Rivaroxaban, an oral direct factor Xa inhibitor
    Piccini, Jonathan P.
    Patel, Manesh R.
    Mahaffey, Kenneth W.
    Fox, Keith A. A.
    Califf, Robert M.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2008, 17 (06) : 925 - 937
  • [23] Chromogenic laboratory assays to measure the factor Xa-inhibiting properties of apixaban-an oral, direct and selective factor Xa inhibitor
    Becker, Richard C.
    Yang, Hongqiu
    Barrett, Yuchen
    Mohan, Puneet
    Wang, Jessie
    Wallentin, Lars
    Alexander, John H.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2011, 32 (02) : 183 - 187
  • [24] Apixaban, a direct factor Xa inhibitor, inhibits tissue-factor induced human platelet aggregation in vitro: Comparison with direct inhibitors of factor VIIa, XIa and thrombin
    Wong, Pancras C.
    Jiang, Xiaosui
    THROMBOSIS AND HAEMOSTASIS, 2010, 104 (02) : 302 - 310
  • [25] Oral factor Xa anticoagulants, rivaroxaban and apixaban, enhance clot dissolution in plasma
    Carter, R. L.
    Talbot, K.
    Smith, T.
    Lee, A. Y.
    Pryzdial, E. L.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 673 - 673
  • [26] Effects of direct thrombin or factor Xa inhibition on clot thrombogenicity in vitro: comparison of dabigatran with rivaroxaban and apixaban
    van Ryn, J.
    Kink-Eiband, M.
    Kuritsch, I
    Wienen, W.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 687 - 688
  • [27] Effects of direct thrombin or factor Xa inhibition on clot thrombogenicity in vitro: Comparison of dabigatran with rivaroxaban and apixaban
    Van Ryn, J.
    Kink-Eiband, M.
    Kuritsch, I.
    Wienen, W.
    EUROPEAN HEART JOURNAL, 2009, 30 : 332 - 333
  • [28] New oral Prophylaxis of venous Thromboembolism, Xa Inhibitor Apixaban factor
    Weiche, Iris
    Bauersachs, Rupert
    HAMOSTASEOLOGIE, 2011, 31 (04): : 310 - 310
  • [29] Effect of apixaban, an oral and direct factor Xa inhibitor, on coagulation activity biomarkers following acute coronary syndrome
    Becker, Richard C.
    Alexander, John H.
    Newby, L. Kristin
    Yang, Hongqiu
    Barrett, Yuchen
    Mohan, Puneet
    Wang, Jessie
    Harrington, Robert A.
    Wallentin, Lars C.
    THROMBOSIS AND HAEMOSTASIS, 2010, 104 (05) : 976 - 983
  • [30] Preclinical discovery of apixaban, a direct and orally bioavailable factor Xa inhibitor
    Wong, Pancras C.
    Pinto, Donald J. P.
    Zhang, Donglu
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2011, 31 (04) : 478 - 492
12345